Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Oct 2, 2024 • 3min
Lab Minute - Iron
Dr. Stacey Clardy, an expert in neurology, dives into the pivotal roles of iron and ferritin in neurological health. She elaborates on how these elements impact conditions like iron deficiency anemia and restless leg syndrome. The discussion navigates the nuances of interpreting ferritin levels, shedding light on the historical connections between iron deficiency and restless legs. It's an enlightening exploration for anyone interested in the intricacies of brain health.
Oct 1, 2024 • 3min
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy
Dr. Rae Bacharach discusses the Neurology Today article, "What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy" by Gina Shaw, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/what_neurologists_should_know_about.2.aspx#:~:text=Neurologists%20frequently%20prescribe%20antidepressants%20for%20managing%20neuropathy%20and,likely%20to%20become%20nonadherent%20to%20control%20their%20weight.
Sep 30, 2024 • 6min
The Topic of Neurological Care for Transgender Patients - Part 3
In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 27, 2024 • 4min
Relapsing-Remitting Immunotherapy Responsive SFN
Dr. Shuvro Roy, a clinician specializing in small-fiber neuropathy, teams up with Dr. Anne Louise Oaklander, a leading expert in the field. They delve into the challenges of diagnosing this often-misunderstood condition, emphasizing the importance of recognizing sensory and autonomic symptoms. The discussion also highlights the exciting potential of immunotherapy for treating autoimmune-related neuropathy, offering fresh insights for clinicians and patients alike.
Sep 26, 2024 • 2min
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society
Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746
Sep 25, 2024 • 4min
The Topic of Neurological Care for Transgender Patients - Part 2
In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 24, 2024 • 4min
The Topic of Neurological Care for Transgender Patients - Part 1
In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 23, 2024 • 2min
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2
In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345
Sep 20, 2024 • 3min
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1
In part one of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss practical tips for recognizing when a patient's response to levodopa may indicate the need for an alternate diagnosis. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345
Sep 19, 2024 • 2min
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496
